European Companies Search Engine
EU funding (€3,961,160): Memory research: Ground-breaking, Applied, and Technological Exchanges Hor 1 Oct 2017 EU Research and Innovation programme "Horizon"
Overview
Text
Memory research: Ground-breaking, Applied, and Technological Exchanges
In M-GATE, ESRs will combine state-of-the art experimental neurophysiology, innovative technologies, and advanced theoretical approaches to unveil memory mechanisms, from single neurons to brain networks, to cognition and behaviour, addressing the healthy and diseased brain. Through research and training from top-class scientists and close interaction with industrial partners, ESRs will develop unique multi-disciplinary skills combining physiology, molecular biology, computation, micro-engineering, and entrepreneurship The exploration of the hippocampal formation and its role in memory is one of the great success stories of neuroscience. For no other structure have neuroscientists achieved such an in-depth knowledge of structure and mechanisms, making this field one of the most promising for breakthroughs in understanding human cognition. Our program will include world-leading, Europe- and US-based scientists in academic institutions as well as pharmaceutical, neurotechnological and machine learning companies, with the task of developing new technologies to understand memory and advance our chances to cure brain pathologies. Early-stage researchers will participate in scientific programs spanning hippocampus research broadly, from local circuital interactions at one brain site, to global networks including multiple brain structures. Dedicated projects will look at brain pathologies as epilepsy and Alzheimer’s from the circuits point of view. A neurotechnology work package spanning multiple projects will include novel methodological developments, bringing together academic and private sector technologists. With the help of targeted secondments and a tailored training program, we provide a unique opportunity for talented researchers to prepare for a career in either academic research or the private sector.
Funded Companies:
| Company name | Funding amount |
| Atlas Neuroengineering BVBA | ? |
| Institut National de la Sante et de la Recherche Medicale | €262,876 |
| Janssen Pharmaceutica N.V. | €250,560 |
| Norges Teknisk-Naturvitenskapelige Universitet Ntnu | €572,550 |
| Scuola Internazionale Superiore Di Studi Avanzati Di Trieste | €516,123 |
| Stichting Radboud Universiteit | €766,123 |
| Universite d'AIX Marseille | €525,751 |
| University College London | €546,576 |
| Weizmann Institute OF Science | €520,601 |
Source: https://cordis.europa.eu/project/id/765549
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Atlas Neuroengineering B.V., Leuven, Belgium.